Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)

Purpose Detection of SARS-CoV-2-infected pregnant women admitted to maternity units during a pandemic is crucial. In addition to the fact that pregnancy is a risk factor for severe COVID-19 and that medical surveillance has to be adjusted in infected women and their offspring, knowledge about infection status can provide the opportunity to protect other patients and healthcare workers against virus transmission. The aim of this prospective observational study was to determine the prevalence of SARS-CoV-2 infection among pregnant women in the hospital setting. Material and Methods All eligible pregnant women admitted to the nine participating hospitals in Franconia, Germany, from 2 June 2020 to 24 January 2021 were included. COVID-19-related symptoms, secondary diseases and pregnancy abnormalities were documented. SARS-CoV-2 RNA was detected by RT-PCR from nasopharyngeal swabs. The prevalence of acute SARS-CoV-2 infection was estimated by correcting the positive rate using the Rogan–Gladen method. The risk of infection for healthcare workers during delivery was estimated using a risk calculator. Results Of 2414 recruited pregnant women, six were newly diagnosed RT-PCR positive for SARS-CoV-2, which yielded a prevalence of SARS-CoV-2 infection of 0.26% (95% CI, 0.10 – 0.57%). Combining active room ventilation and wearing FFP2 masks showed an estimated reduction of risk of infection for healthcare workers in the delivery room to < 1%. Conclusions The prevalence of newly diagnosed SARS-CoV-2 infection during pregnancy in this study is low. Nevertheless, a systematic screening in maternity units during pandemic situations is important to adjust hygienic and medical management. An adequate hygienic setting can minimise the calculated infection risk for medical healthcare workers during patientsʼ labour.

[1]  M. Rüdiger,et al.  Neonatal outcome following maternal infection with SARS-CoV-2 in Germany: COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS) , 2021, Archives of Disease in Childhood.

[2]  A. Papageorghiou,et al.  Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection , 2021, JAMA pediatrics.

[3]  M. Baldini,et al.  Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak , 2021, Acta bio-medica : Atenei Parmensis.

[4]  Ravindra K. Gupta,et al.  Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review , 2021, BMC Pregnancy and Childbirth.

[5]  J. Pum,et al.  Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study , 2021, Journal of Clinical Virology.

[6]  F. Pérez-López,et al.  Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing , 2021, Life Sciences.

[7]  S. Solomon,et al.  Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. , 2021, JAMA internal medicine.

[8]  T. Issat,et al.  No COVID-19 Cases Detected Between April and September 2020 After Screening All 838 Admissions to a Maternity Unit in Poland , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[9]  M. Rüdiger,et al.  Pregnancy and SARS-CoV-2 Infection in Germany-the CRONOS Registry. , 2020, Deutsches Arzteblatt international.

[10]  M. Nöthen,et al.  Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany , 2020, Nature Communications.

[11]  E. Draper,et al.  Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance , 2020, The Lancet Child & Adolescent Health.

[12]  E. Olsen,et al.  Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[13]  E. Olsen,et al.  Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[14]  A. Benachi,et al.  Synthesis and systematic review of reported neonatal SARS-CoV-2 infections , 2020, Nature Communications.

[15]  M. Gismondo,et al.  Analysis of SARS-CoV-2 vertical transmission during pregnancy , 2020, Nature Communications.

[16]  J. Nien,et al.  Routine screening for SARS CoV-2 in unselected pregnant women at delivery , 2020, PloS one.

[17]  S. McLafferty,et al.  Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[18]  Stephan Borrmann,et al.  Aerosol transmission of COVID-19 and infection risk in indoor environments , 2020, medRxiv.

[19]  Ephrem Awulachew,et al.  The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal–fetal transmission: a systematic review and meta-analysis , 2020, European Journal of Medical Research.

[20]  L. Mofenson,et al.  Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis , 2020, BMJ.

[21]  T. Yeo,et al.  Viral dynamics and immune correlates of COVID-19 disease severity , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  F. Gorlero,et al.  Asymptomatic SARS‐CoV‐2 infections in pregnant patients in an Italian city during the complete lockdown , 2020, Journal of medical virology.

[23]  J. Masci,et al.  Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York , 2020, medRxiv.

[24]  M. Giles,et al.  COVID‐19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission , 2020, The Australian & New Zealand journal of obstetrics & gynaecology.

[25]  U. Pecks,et al.  Perinatale Aspekte der SARS-CoV-2 Infektion , 2020, Zeitschrift für Geburtshilfe und Neonatologie.

[26]  K. Hecher,et al.  [Update on Recommendations for SARS-CoV-2/COVID-19 During Pregnancy, Birth and Childbed]. , 2020, Zeitschrift fur Geburtshilfe und Neonatologie.

[27]  A. Scherag,et al.  [Period Prevalence of SARS-CoV-2 in an Unselected Sample of Pregnant Women in Jena, Thuringia]. , 2020, Zeitschrift fur Geburtshilfe und Neonatologie.

[28]  S. Unlu,et al.  The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[29]  Lingkong Zeng,et al.  Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From the Mother to the Infant-Reply. , 2020, JAMA pediatrics.

[30]  I. Burd,et al.  COVID‐19 in pregnancy: Placental and neonatal involvement , 2020, American journal of reproductive immunology.

[31]  G. Sotgiu,et al.  COVID-19 in pregnant women: A systematic review and meta-analysis , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[32]  H. Honest,et al.  Maternal COVID-19 infection, clinical characteristics, pregnancy, and neonatal outcome: A prospective cohort study , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[33]  D. Skupski,et al.  Pregnancy and postpartum outcomes in a universally tested population for SARS‐CoV‐2 in New York City: a prospective cohort study , 2020, BJOG : an international journal of obstetrics and gynaecology.

[34]  L. Magee,et al.  SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes , 2020, EClinicalMedicine.

[35]  S. Gilboa,et al.  Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[36]  Zunyou Wu,et al.  Asymptomatic and Pre-Symptomatic COVID-19 in China , 2020, Infectious Diseases of Poverty.

[37]  J. Dorling,et al.  Maternal transmission of SARS‐COV‐2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis , 2020, BJOG : an international journal of obstetrics and gynaecology.

[38]  P. Brocklehurst,et al.  Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study , 2020, BMJ.

[39]  A. Peaceman,et al.  Clinical Implications of Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Pregnancy. , 2020, Obstetrics and gynecology.

[40]  A. Khalil,et al.  COVID-19 screening of health-care workers in a London maternity hospital , 2020, The Lancet Infectious Diseases.

[41]  M. Arosio,et al.  Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019–positive mothers and neonates at birth , 2020, American Journal of Obstetrics & Gynecology Mfm.

[42]  M. Arosio,et al.  Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth , 2020, American Journal of Obstetrics & Gynecology MFM.

[43]  A. Khalil,et al.  Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg , 2020, American Journal of Obstetrics and Gynecology.

[44]  M. Haghshenas,et al.  Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID‐19 infection , 2020, Prenatal Diagnosis.

[45]  Dena Goffman,et al.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery , 2020, The New England journal of medicine.

[46]  Jian Wang,et al.  Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. , 2020, JAMA.

[47]  M. Beckmann,et al.  SARS-CoV-2 Infection in Pregnancy – a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome , 2020, Geburtshilfe und Frauenheilkunde.

[48]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[49]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[50]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[51]  H. Melchior,et al.  The Prevalence of Gestational Diabetes. , 2017, Deutsches Arzteblatt international.

[52]  B. Gladen,et al.  Estimating prevalence from the results of a screening test. , 1978, American journal of epidemiology.